ADAPT platform for antibody affinity maturation (T-90201) .: NR16-171/2017E-PDF
“To aid in the selection and rationalization of mutants that improve and/or modulate the affinity of antibodies and other biologics, the NRC has developed an efficient platform called ADAPT (Assisted Design of Antibody and Protein Therapeutics). ADAPT interleaves computational predictions with experimental validation, significantly aiding the design of protein therapeutics by guiding the selection of optimal mutations”--Highlights, p. [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847426&sl=0
| Department/Agency |
|
|---|---|
| Title | ADAPT platform for antibody affinity maturation (T-90201) . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Digital text |
| Electronic document | |
| Note(s) |
|
| Publishing information |
|
| Description | [2] p. : col. ill. |
| ISBN | 9780660239132 |
| Catalogue number |
|
| Subject terms |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: